Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;10(1):26-36.
doi: 10.1080/21505594.2018.1556150.

Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages

Affiliations

Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages

Adithap Hansakon et al. Virulence. 2019 Dec.

Abstract

Cryptococcus-macrophage interaction is crucial in the development of cryptococcocal diseases. C. neoformans and C. gattii are major pathogenic species that occupy different niches and cause different clinical manifestations. However, the differences of macrophage interaction among these species in affecting different disease outcomes and immune responses have not been clearly addressed. Here, we examined the macrophage uptake rates, intracellular loads and intracellular proliferation rates of C. neoformans and C. gattii clinical isolates from Thailand and analyzed the effect of those interactions on fungal burdens and host immune responses. C. neoformans isolates showed a higher phagocytosis rate but lower intracellular proliferation rate than C. gattii. Indeed, the high intracellular proliferation rate of C. gattii isolates did not influence the fungal burdens in lungs and brains of infected mice, whereas infection with high-uptake C. neoformans isolates resulted in significantly higher brain burdens that associated with reduced survival rate. Interestingly, alveolar macrophages of mice infected with high-uptake C. neoformans isolates showed distinct patterns of alternatively activated macrophage (M2) gene expressions with higher Arg1, Fizz1, Il13 and lower Nos2, Ifng, Il6, Tnfa, Mcp1, csf2 and Ip10 transcripts. Corresponding to this finding, infection with high-uptake C. neoformans resulted in enhanced arginase enzyme activity, elevated IL-4 and IL-13 and lowered IL-17 in the bronchoalveolar lavage. Thus, our data suggest that the macrophage interaction with C. neoformans and C. gattii may affect different disease outcomes and the high phagocytosis rates of C. neoformans influence the induction of type-2 immune responses that support fungal dissemination and disease progression. Abbreviation: Arg1: Arginase 1; BAL: Bronchoalveolar lavage; CCL17: Chemokine (C-C motif) ligand 17; CNS: Central nervous system; CSF: Cerebrospinal fluid; Csf2: Colony-stimulating factor 2; Fizz1: Found in inflammatory zone 1; HIV: Human immunodeficiency virus; ICL: Intracellular cryptococcal load; Ifng: Interferon gamma; Ip10: IFN-g-inducible protein 10; IPR: Intracellular proliferation rate; Mcp1: Monocyte chemoattractant protein 1; Nos2: Nitric oxide synthase 2; PBS: Phosphate-Buffered Saline; Th: T helper cell; Tnfa: Tumor necrosis factor alpha.

Keywords: Cryptococcus gattii; Cryptococcus neoformans; fungal uptake; immune responses; macrophages.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Phagocytic uptake, intracellular load and proliferation rate of C. neoformans and C. gatii clinical isolates by macrophages. The J774 macrophage was infected by clinical isolates of C. neoformans and C gattii at a 1:10 ratio followed by lysis at 2, 18 and 24 h postinfection to determine cryptococcal uptake at 2 h, intracellular loads (ICL) at 18 h and 24 h and intracellular proliferation rate (IPR) at 18 h and 24 h by (a – e) counting with hemocytometer and (f-j) enumerating using CFU assay. Each dot represents one clinical isolate. Results were expressed as the mean of 3 to 6 experimental repeats. Error bars denote mean ± SD. Significance was determined using unpaired t test (2-tailed) * p <0.05, ** p <0.01, ns = not significantly different.
Figure 2.
Figure 2.
Association of the cryptococcal uptake of C. neoformans and C. gattii clinical isolate with intracellular load and proliferation within macrophages. C. neoformans and C. gattii clinical isolates were independently exposed to J774 macrophages and followed by determining the uptake rate, intracellular loads (ICL) and intracellular proliferation rate (IPR) at 24 h postinfection. The correlation between uptake rate and ICL of C. neoformans (a) or of C. gattii (b) clinical isolates was evaluated. The uptake rate of C. neoformans (c) or of C. gattii (d) was also assessed for the correlation to IPR. Spearman’s rank test was used to determine the correlation between the uptake rate, ICL and IPR. Correlation coefficients (r) and p-values were given for each correlation. * p <0.05, ** p <0.01, *** p <0.001 and ns = not significantly correlated.
Figure 3.
Figure 3.
Mice infected with high-uptake C. neoformans isolates exhibited higher brain fungal burdens and had reduced survival rate. C. neoformans isolates were selected to represent the top 4 high-uptake and bottom 4 low-uptake strains and C. gattii isolates were selected to represent the top 4 high IPR and bottom 4 low IPR strains based on J774 macrophage uptake and IPR profiles. (a-d) BALB/c mice were intranasal infected with high- (HU) and low- (LU) uptake C. neoformans isolates or high (HIPR) and low IPR (LIPR) C. gattii isolates. Lung and brain fungal burdens of mice infected with C. neoformans (a, b) and C. gattii (c, d) were enumerated at 14 d postinfection. Graphs depict mean ± SD and are representative of 3 experiments with 3 to 5 mice per group. Significance was determined using unpaired t test (2-tailed) ** p <0.01, ns = not significantly different. (e) For survival analysis, BALB/c mice were infected with the high- (HU, solid line) or low- (LU, dot line) uptake strain of C. neoformans and were monitored for their survival daily for 60 d. Survival curves were generated from the results obtained with 8 mice per strain and evaluated for statistical significance with Kaplan-Meier survival curves, and P values were obtained from a log-rank test, ** p <0.01.
Figure 4.
Figure 4.
Infection with high-uptake C. neoformans strains induced alveolar macrophages with higher expression of genes related to M2 macrophage. BALB/c mice received PBS or were infected with the top 4 high-and the top 4 low-uptake C. neoformans isolates. (a) Alveolar macrophages were isolated from the bronchoalveolar lavage of each mouse at 14 d postinfection and total RNA was isolated and subjected to cDNA synthesis, followed by real-time PCR analysis of gene for M1 and M2 including Arg1, Fizz1, Ym1, Il13, Ccl17, Nos2, Ifng, Il6, Tnfa, Mcp1, Csf2 and Ip10. Data were expressed as fold induction over actin (Actb) expression, with the mRNA levels in the PBS control set as 1. (b) Bronchoalveolar lavages of PBS-treated mice and high-uptake and low-uptake C. neoformans-infected mice were collected and the arginase enzyme activity was determined by photometric measurement of produced urea concentration. Graphs depict mean ± SD and are representative of 3 experiments with 3 to 5 mice per group. Significance was determined by one-way ANOVA with Tukey’s post hoc analysis * p <0.05, ** p <0.01, ***p <0.001.
Figure 5.
Figure 5.
High-uptake C. neoformans potentiated the induction of type 2 immune responses and reduced type-17 immune responses in the lungs. BALB/c mice received PBS or were infected with the top 4 high-and the top 4 low-uptake C. neoformans isolates. (a) The bronchoalveolar lavages were collected and assessed for cytokine production at 14 d postinfection. (b) Lung draining lymph nodes were harvested and cell suspensions were prepared to analyze antigen-specific cytokine production. After lymph node cells were stimulated with heat-killed Cryptococcus cells for 72 h, supernatant was collected and subjected to analyze cytokines by ELISA. Graphs depict mean ± SD and are representative of 3 experiments with 3 to 5 mice per group. Significance was determined by one-way ANOVA with Tukey’s post hoc analysis * p <0.05, ** p <0.01 and *** p <0.001.

References

    1. Huston SM, Mody CH.. Cryptococcosis: an emerging respiratory mycosis. Clin Chest Med. 2009;30:253–64, vi. - PubMed
    1. Smith RM, Mba-Jonas A, Tourdjman M, et al. Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest. PLoS One. 2014;9:e88875. - PMC - PubMed
    1. Ngamskulrungroj P, Chang Y, Sionov E, et al. The primary target organ of cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. MBio. 2012;3. - PMC - PubMed
    1. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis. 1995;21:28–34. discussion 5–6. - PubMed
    1. Buchanan KL, Doyle HA. Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Infect Immun. 2000;68:456–462. - PMC - PubMed

Publication types

MeSH terms